Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 14 | 2016 | 814 | 0.970 |
Why?
|
| Herpes Zoster | 8 | 2020 | 82 | 0.780 |
Why?
|
| Vascular Calcification | 1 | 2018 | 8 | 0.590 |
Why?
|
| Ankle Brachial Index | 1 | 2018 | 7 | 0.580 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 58 | 0.570 |
Why?
|
| Body Weight | 7 | 2013 | 203 | 0.560 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 112 | 0.540 |
Why?
|
| Risk Assessment | 4 | 2018 | 1076 | 0.480 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 532 | 0.470 |
Why?
|
| Continental Population Groups | 4 | 2013 | 286 | 0.420 |
Why?
|
| Child | 21 | 2020 | 2403 | 0.410 |
Why?
|
| Adolescent | 22 | 2020 | 3538 | 0.380 |
Why?
|
| Body Height | 3 | 2010 | 60 | 0.370 |
Why?
|
| Humans | 37 | 2020 | 17314 | 0.360 |
Why?
|
| Female | 33 | 2020 | 12396 | 0.350 |
Why?
|
| Herpes Zoster Vaccine | 4 | 2013 | 59 | 0.350 |
Why?
|
| Birth Certificates | 1 | 2010 | 24 | 0.340 |
Why?
|
| Ethnic Groups | 2 | 2011 | 451 | 0.340 |
Why?
|
| California | 18 | 2013 | 2311 | 0.340 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 70 | 0.330 |
Why?
|
| Child, Preschool | 14 | 2019 | 1380 | 0.330 |
Why?
|
| Male | 26 | 2020 | 9804 | 0.300 |
Why?
|
| Young Adult | 17 | 2020 | 2465 | 0.290 |
Why?
|
| Overweight | 5 | 2016 | 266 | 0.290 |
Why?
|
| Infant | 9 | 2020 | 1161 | 0.290 |
Why?
|
| Prevalence | 12 | 2013 | 840 | 0.290 |
Why?
|
| Electronic Health Records | 3 | 2020 | 704 | 0.270 |
Why?
|
| Prenatal Care | 2 | 2020 | 127 | 0.260 |
Why?
|
| Vaccination | 5 | 2020 | 688 | 0.260 |
Why?
|
| Adult | 15 | 2020 | 7500 | 0.250 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2019 | 151 | 0.240 |
Why?
|
| Body Mass Index | 9 | 2013 | 937 | 0.240 |
Why?
|
| Chickenpox Vaccine | 4 | 2020 | 91 | 0.230 |
Why?
|
| Hypertension | 3 | 2013 | 469 | 0.220 |
Why?
|
| Preventive Health Services | 2 | 2016 | 147 | 0.220 |
Why?
|
| Weight Loss | 2 | 2020 | 294 | 0.220 |
Why?
|
| Retrospective Studies | 12 | 2020 | 2415 | 0.220 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 151 | 0.220 |
Why?
|
| Weight Reduction Programs | 2 | 2016 | 49 | 0.210 |
Why?
|
| Infant, Newborn | 4 | 2019 | 805 | 0.200 |
Why?
|
| Risk Factors | 9 | 2018 | 3258 | 0.200 |
Why?
|
| Cross-Sectional Studies | 11 | 2013 | 1280 | 0.200 |
Why?
|
| Cohort Studies | 12 | 2020 | 2514 | 0.200 |
Why?
|
| Psoriasis | 2 | 2011 | 9 | 0.180 |
Why?
|
| Hispanic Americans | 3 | 2012 | 375 | 0.170 |
Why?
|
| Papillomavirus Infections | 2 | 2020 | 142 | 0.170 |
Why?
|
| Incidence | 7 | 2020 | 1266 | 0.170 |
Why?
|
| Mumps | 1 | 2020 | 12 | 0.160 |
Why?
|
| Condylomata Acuminata | 1 | 2020 | 23 | 0.160 |
Why?
|
| Chickenpox | 1 | 2020 | 35 | 0.160 |
Why?
|
| Clinical Trials as Topic | 2 | 2018 | 120 | 0.160 |
Why?
|
| Measles | 1 | 2020 | 24 | 0.160 |
Why?
|
| Hepatitis A Virus, Human | 1 | 2019 | 5 | 0.160 |
Why?
|
| Hepatitis A | 1 | 2019 | 11 | 0.160 |
Why?
|
| Hepatitis A Vaccines | 1 | 2019 | 15 | 0.160 |
Why?
|
| Odds Ratio | 4 | 2018 | 640 | 0.150 |
Why?
|
| Papillomavirus Vaccines | 1 | 2020 | 114 | 0.150 |
Why?
|
| Hepatitis B Vaccines | 1 | 2018 | 44 | 0.140 |
Why?
|
| African Americans | 2 | 2012 | 439 | 0.140 |
Why?
|
| Central Venous Catheters | 1 | 2018 | 3 | 0.140 |
Why?
|
| Catheterization, Central Venous | 1 | 2018 | 11 | 0.140 |
Why?
|
| Proteinuria | 1 | 2018 | 25 | 0.140 |
Why?
|
| Renal Dialysis | 1 | 2018 | 57 | 0.140 |
Why?
|
| Biomarkers | 1 | 2018 | 307 | 0.130 |
Why?
|
| Pregnancy | 5 | 2020 | 1463 | 0.120 |
Why?
|
| Antibodies, Viral | 2 | 2020 | 66 | 0.120 |
Why?
|
| Preconception Care | 1 | 2016 | 40 | 0.120 |
Why?
|
| Middle Aged | 10 | 2019 | 7836 | 0.120 |
Why?
|
| Contraceptives, Oral | 2 | 2013 | 25 | 0.120 |
Why?
|
| Dental Care | 1 | 2015 | 16 | 0.120 |
Why?
|
| Datasets as Topic | 1 | 2015 | 20 | 0.120 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2015 | 32 | 0.120 |
Why?
|
| Socioeconomic Factors | 3 | 2013 | 605 | 0.120 |
Why?
|
| Advisory Committees | 1 | 2016 | 112 | 0.120 |
Why?
|
| Adenoma | 1 | 2016 | 95 | 0.120 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 53 | 0.110 |
Why?
|
| Metabolic Syndrome | 2 | 2012 | 65 | 0.110 |
Why?
|
| Managed Care Programs | 2 | 2013 | 300 | 0.110 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 109 | 0.110 |
Why?
|
| United States | 7 | 2019 | 3866 | 0.110 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 197 | 0.110 |
Why?
|
| Prehypertension | 1 | 2013 | 21 | 0.100 |
Why?
|
| Lower Extremity | 1 | 2013 | 12 | 0.100 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2013 | 18 | 0.100 |
Why?
|
| Prepaid Health Plans | 2 | 2010 | 18 | 0.100 |
Why?
|
| Phosphorus | 1 | 2013 | 6 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 342 | 0.100 |
Why?
|
| Drug Utilization | 1 | 2013 | 121 | 0.100 |
Why?
|
| Kidney | 1 | 2013 | 52 | 0.100 |
Why?
|
| Aged | 8 | 2018 | 6084 | 0.100 |
Why?
|
| Gallstones | 1 | 2012 | 14 | 0.100 |
Why?
|
| Arm Injuries | 1 | 2012 | 4 | 0.100 |
Why?
|
| Leg Injuries | 1 | 2012 | 7 | 0.100 |
Why?
|
| Contraception | 1 | 2012 | 24 | 0.100 |
Why?
|
| Fractures, Bone | 1 | 2013 | 92 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2015 | 292 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2015 | 282 | 0.090 |
Why?
|
| Musculoskeletal Pain | 1 | 2012 | 24 | 0.090 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2012 | 6 | 0.090 |
Why?
|
| Censuses | 1 | 2012 | 28 | 0.090 |
Why?
|
| Dyslipidemias | 1 | 2012 | 56 | 0.090 |
Why?
|
| Lipids | 1 | 2011 | 69 | 0.090 |
Why?
|
| Asian Americans | 1 | 2012 | 163 | 0.090 |
Why?
|
| Health Planning | 1 | 2010 | 16 | 0.090 |
Why?
|
| Quality Control | 1 | 2010 | 41 | 0.090 |
Why?
|
| Patient Selection | 1 | 2012 | 176 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2012 | 149 | 0.080 |
Why?
|
| Pneumococcal Vaccines | 1 | 2011 | 68 | 0.080 |
Why?
|
| Catchment Area (Health) | 1 | 2010 | 8 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2010 | 231 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 622 | 0.080 |
Why?
|
| Health Surveys | 1 | 2011 | 245 | 0.080 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 77 | 0.080 |
Why?
|
| European Continental Ancestry Group | 1 | 2012 | 476 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 310 | 0.080 |
Why?
|
| Pregnancy Outcome | 2 | 2020 | 158 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 202 | 0.070 |
Why?
|
| Asthma | 1 | 2012 | 400 | 0.070 |
Why?
|
| Health Status | 1 | 2010 | 293 | 0.070 |
Why?
|
| Mass Screening | 1 | 2013 | 672 | 0.070 |
Why?
|
| Logistic Models | 3 | 2018 | 879 | 0.070 |
Why?
|
| Delivery of Health Care | 1 | 2010 | 390 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2012 | 535 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 664 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2011 | 437 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2015 | 270 | 0.050 |
Why?
|
| Immunocompetence | 2 | 2012 | 10 | 0.050 |
Why?
|
| Comorbidity | 2 | 2013 | 560 | 0.040 |
Why?
|
| Pregnancy Trimesters | 1 | 2020 | 29 | 0.040 |
Why?
|
| Alphapapillomavirus | 1 | 2020 | 13 | 0.040 |
Why?
|
| Northwestern United States | 1 | 2020 | 53 | 0.040 |
Why?
|
| Vaccines, Combined | 1 | 2020 | 80 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 701 | 0.040 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2020 | 62 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2019 | 43 | 0.040 |
Why?
|
| Mass Vaccination | 1 | 2019 | 22 | 0.040 |
Why?
|
| Sex Factors | 2 | 2012 | 603 | 0.040 |
Why?
|
| Hepatitis B | 1 | 2018 | 45 | 0.040 |
Why?
|
| Age Factors | 2 | 2010 | 878 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 1039 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 1160 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 1925 | 0.030 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2016 | 10 | 0.030 |
Why?
|
| DNA | 1 | 2016 | 23 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2016 | 25 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2016 | 26 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 45 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2016 | 27 | 0.030 |
Why?
|
| Sigmoidoscopy | 1 | 2016 | 65 | 0.030 |
Why?
|
| Data Accuracy | 1 | 2016 | 24 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 85 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 298 | 0.030 |
Why?
|
| Seasons | 1 | 2015 | 113 | 0.030 |
Why?
|
| Propensity Score | 1 | 2015 | 76 | 0.030 |
Why?
|
| Occult Blood | 1 | 2016 | 155 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 312 | 0.030 |
Why?
|
| Weight Gain | 1 | 2016 | 156 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 124 | 0.030 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2015 | 215 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2016 | 257 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 535 | 0.030 |
Why?
|
| Anthropometry | 1 | 2013 | 60 | 0.030 |
Why?
|
| Demography | 1 | 2013 | 93 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 139 | 0.020 |
Why?
|
| Social Class | 1 | 2013 | 116 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 87 | 0.020 |
Why?
|
| Thinness | 1 | 2012 | 31 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 153 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2012 | 48 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 180 | 0.020 |
Why?
|
| Oceanic Ancestry Group | 1 | 2012 | 33 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2012 | 57 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 66 | 0.020 |
Why?
|
| Income | 1 | 2012 | 86 | 0.020 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2012 | 89 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 177 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2011 | 23 | 0.020 |
Why?
|
| African Continental Ancestry Group | 1 | 2012 | 144 | 0.020 |
Why?
|
| Dermatology | 1 | 2011 | 6 | 0.020 |
Why?
|
| Arthritis, Psoriatic | 1 | 2011 | 5 | 0.020 |
Why?
|
| Phototherapy | 1 | 2011 | 23 | 0.020 |
Why?
|
| Adolescent Development | 1 | 2011 | 11 | 0.020 |
Why?
|
| Data Collection | 1 | 2012 | 238 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 70 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 357 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 123 | 0.020 |
Why?
|
| Pneumococcal Infections | 1 | 2011 | 44 | 0.020 |
Why?
|
| Health Services Research | 1 | 2012 | 202 | 0.020 |
Why?
|
| Obesity, Morbid | 1 | 2012 | 119 | 0.020 |
Why?
|
| Poverty | 1 | 2012 | 168 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2011 | 86 | 0.020 |
Why?
|
| Child Development | 1 | 2011 | 53 | 0.020 |
Why?
|
| Virus Activation | 1 | 2010 | 5 | 0.020 |
Why?
|
| Herpesvirus 3, Human | 1 | 2010 | 44 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2012 | 253 | 0.020 |
Why?
|
| Pediatrics | 1 | 2011 | 142 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 1151 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 384 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 397 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1098 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2011 | 726 | 0.010 |
Why?
|
Concepts
(201)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->